Arkansas,which plans to resume lethal injections next month, has avoided Hikma Pharmaceuticals’ inquiries, or citing current secrecy law on execution policiesA British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine whether the state plans to use them anyway,but prison officials are dismissing inquiries approximately the drug by citing a current law that makes all execution policies an official state secret.
Hikma Pharmaceuticals canceled a contract with Arkansas prison officials in 2013, after it learned the state purchased a seizure medication and another drug to use in lethal injections from one of its US subsidiaries.
Continue reading...
Source: theguardian.com